Philadelphia, PA (PRWEB) October 25, 2007
One of the key challenges within pharmaceutical R&D organizations is properly embedding the portfolio, project and resource management capability in the overall decision making process. At the Kinapse Project and Resource Management (PRM) Forum held on October 11, 2007 in Philadelphia PA, R&D executives from several major pharmaceutical companies gathered to discuss this challenge and provide perspectives from their experiences, including the organizational, process, and technological factors in operating world class project and resource management.
As the pharmaceutical industry continues to seek opportunities to increase the efficiency and lower the cost of bringing drugs through the development process, R&D organizations are implementing capabilities that combine portfolio, project, and resource utilization to enable them to better adapt to the resource needs of their R&D pipeline.
Paul Biondi, Head of R&D Operations for Bristol-Myers Squibb commented on the event, "As an industry, we are clearly looking for ways to both improve yields within R&D and also to better manage our costs and investments. The meeting reinforced how most major R&D organizations are making strides in increasing their planning and resource management capabilities to drive better portfolio and operational decisions, yet there are still significant opportunities to improve. At BMS, we feel we've made important strides in utilizing these tools to make better investment decisions."
Tobias Hoppe, President of Kinapse US, and formerly responsible for global project management at Nycomed added: "Effective PRM practices are going to play a vital role in the ability of an R&D organization to make difficult resource management decisions. Those companies that are able to implement these solutions quickly will be at a significant competitive advantage."
The event was hosted by the Kinapse CEO, Andy Black. He commented on the event. "PRM is an area where our clients particularly value our consulting and information processing services. There is clearly significant benefit to be obtained from a vendor-neutral network of industry professionals to continue to exchange experience and ideas, so we will explore running further events for additional parties as part of an ongoing community of practice."
Kinapse provides specialist information processing services and business consulting to life sciences R&D organisations at unmatched value.
Kinapse has a proven delivery model that allows it to bring together the very best people in global project teams in a wide range of R&D domains with total commitment to the success of our clients. The delivery model is differentiated from conventional R&D services companies by:
- blended onshore-offshore teams, tailored to client requirements;
- industry-veteran Consulting Partners who bring deep experience and expertise in specific functional areas;
- exclusive Service Partners with distinctive, complementary services.
Kinapse personnel have worked with many of the world's top pharmaceutical and biotechnology companies in consulting and information processing engagements.
Tobias Hoppe, President Kinapse Inc:
Tim Ehrman, Senior Manager, Kinapse Inc
+1 610 977 2021
(For parties interested in joining a PRM Community of Practice)